Inhibitory signals mediated by programmed death-1 are involved with t-cell function in chronic periodontitis

Journal of Periodontology

Volumn 80, Issue 11, 2009, Pages 1833-1844

  Figueira, Eduardo Aleixo ^a   De Rezende, Maria Lućia Rubo ^a   Torres, Sergio Aparecido ^a   Garlet, Gustavo Pompermaier ^a   Lara, Vanessa Soares ^a   Santos, Carlos Ferreira ^a   Avila Campos, Mario Julio ^a   Silva, João Santana Da ^a   Campanelli, Ana Paula ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Interferon gamma; Interleukin 10; Lymphocyte activation; Periodontitis; T lymphocyte subsets

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BACTERIAL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; ARTICLE; BLOOD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; DOWN REGULATION; FEMALE; GINGIVA; GINGIVITIS; HUMAN; IMMUNOLOGY; LEUKOCYTE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; AGED; AGED, 80 AND OVER; ALVEOLAR BONE LOSS; ANTIGENS, BACTERIAL; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC PERIODONTITIS; DOWN-REGULATION; FEMALE; GINGIVA; GINGIVITIS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 72349094268     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090057     Document Type: Article

References (48)

1. do Vale CH, de Oliveira Fraga LA, Costa AS, et al. Antiproliferative activity of Actinobacillus (Haemo-philus) actinomycetemcomitans and Fusobacterium nucleatum in peripheral blood mononuclear cells. Res Microbiol 2004;155:731-740.
2. Shenker BJ, McArthur WP, Tsai CC. Immune suppression induced by Actinobacillus actinomycetemcomi-tans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J Immunol 1982;128:148-154.
3. Shenker BJ, Vitale L, Slots J. Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation. Infect Immun 1991;59:4583-4589.
4. Takahashi K, Akutsu I, Arai H, et al. Assessment of in vitro interleukin-2-producing capacity of peripheral blood lymphocytes from patients with periodontitis. J Clin Periodontol 1997;24:44-50.
5. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998;280:243-248.
6. Benard G, Romano CC, Cacere CR, Juvenale M, Mendes-Giannini MJ, Duarte AJ. Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosup-pression associated with human paracoccidioidomy-cosis. Cytokine 2001;13:248-252.
7. Carreno BM, Collins M. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002;20:29-53.
8. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515-548.
9. Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunother-apy. Annu Rev Immunol 2001;19:565-594.
10. Liang SC, Latchman YE, Buhlmann JE, et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 2003;33:2706-2716.
11. Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000;192:1027-1034.
12. Chambers CA, Krummel MF, Boitel B, et al. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 1996;153:27-46.
13. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11:141-151.
14. Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001;291:319-322.
15. Okazaki T, Tanaka Y, Nishio R, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003;9:1477-1483.
16. Gemmell E, Seymour GJ. Different responses in B cells induced by Porphyromonas gingivalis and Fusobacte-rium nucleatum. Arch Oral Biol 1992;37:565-573.
17. Kinder Haake S, Lindemann RA. Fusobacterium nu-cleatum T18 aggregates human mononuclear cells and inhibits their PHA-stimulated proliferation. J Periodontol 1997;68:39-44.
18. Shenker BJ, DiRienzo JM. Suppression of human peripheral blood lymphocytes by Fusobacterium nu-cleatum. J Immunol 1984;132:2357-2362.
19. Garlet GP, Martins W Jr., Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003;38:210-217.
20. Garlet GP, Martins W Jr., Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004;31:671-679.
21. Avila-Campos MJ, Carvalho MA, Zelante F. Distribution of biotypes and antimicrobial susceptibility of Actinobacillus actinomycetemcomitans. Oral Micro-biol Immunol 1995;10:382-384.
22. Emingil G, Karaarslan F, Keskinoglu A, Coker I, Atilla G. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients. J Int Acad Periodontol 2001;3:87-94.
23. Baker PJ. The role of immune responses in bone loss during periodontal disease. Microbes Infect 2000;2:1181-1192.
24. Gemmell E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 2002;13:17-34.
25. Genco RJ. Host responses in periodontal diseases: Current concepts. J Periodontol 1992;63:338-355.
26. Petit MD, Hovenkamp E, Hamann D, et al. Phenotyp-ical and functional analysis of T cells in periodontitis. J Periodontal Res 2001;36:214-220.
27. Teng YT. The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med 2003;14:237-252.
28. Carter L, Fouser LA, Jussif J, et al. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002;32:634-643.
29. Fujihashi K, Beagley KW, Kono Y, et al. Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4. Am J Pathol 1993;142:1239-1250.
30. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443:350-354.
31. Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006;203:2281-2292.
32. Trautmann L, Janbazian L, Chomont N, et al. Upre-gulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006;12:1198-1202.
33. Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008;45:963-970.
34. Aoyagi T, Yamazaki K, Kabasawa-Katoh Y, et al. Elevated CTLA-4 expression on CD4 T cells from periodontitis patients stimulated with Porphyromonas gingivalis outer membrane antigen. Clin Exp Immunol 2000;119:280-286.
35. Pietrella D, Perito S, Bistoni F, Vecchiarelli A. Cytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Crypto-coccus neoformans. Infect Immun 2001;69:1508-1514.
36. Saverino D, Merlo A, Bruno S, Pistoia V, Grossi CE, Ciccone E. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol 2002;168:207-215.
37. Brown JA, Dorfman DM, Ma FR, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 2003;170:1257-1266.
38. O'Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage. J Clin Invest 2004;114:1372-1378.
39. Vieth M, Will A, Schroppel K, Rollinghoff M, Gessner A. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand J Immunol 1994;40:403-409.
40. Gorska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalinski K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30:1046-1052.
41. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis. J Dent 2004;32:511-520.
42. Kobayashi M, Kawano S, Hatachi S, et al. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjog̈ren's Syndrome. J Rheumatol 2005;32:2156-2163.
43. Keir ME, Francisco LM, Sharpe AH. PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 2007;19:309-314.
44. Honda T, Domon H, Okui T, Kajita K, Amanuma R, Yamazaki K. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin Exp Immunol 2006;144:35-40.
45. Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD4(+) T cells and the proinflamma-tory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999;67:2804-2809.
46. Garlet GP, Cardoso CR, Campanelli AP, et al. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: Host protection and tissue destruction. Clin Exp Immunol 2007;147:128-138.
47. Garlet GP, Cardoso CR, Silva TA, et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actino-mycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Micro-biol Immunol 2006;21:12-20.
48. Teng YT, Mahamed D, Singh B. Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo. Infect Immun 2005;73:3453-3461.